Cystic Duct Embolization with Chemical Gallbladder Ablation for the Treatment of Acute Calculous Cholecystitis in High-Risk Patients: A Prospective Single-Center Study

J Vasc Interv Radiol. 2020 Apr;31(4):644-648. doi: 10.1016/j.jvir.2019.12.806. Epub 2020 Mar 4.

Abstract

Purpose: To demonstrate the feasibility of cystic duct embolization and chemical gallbladder ablation as an alternative to cholecystectomy in high-risk patients with calculous cholecystitis who were not candidates for surgery.

Materials and methods: This prospective study included 10 patients with acute cholecystitis (7 males and 3 females) aged 70-91 years (average age, 81.6 years) between 2013 and 2019. A cholecystostomy catheter was inserted during the acute phase, followed by cystic duct coil embolization performed via the existing drainage tube tract. Once asymptomatic, 3% aethoxysklerol was injected into the gallbladder, and the drain was removed upon sonographic confirmation that the gallbladder remained contracted. Each phase of the procedure was performed with an interval of 2-3 weeks. Clinical, cholangiographic, and sonographic data were collected before and after drain removal at 1-month follow-up.

Results: Cystic duct embolization was technically successful in all patients, with no immediate post-procedure complications. Gallbladder ablation performed in 10 patients was technically successful in all of them (median follow-up, 11 months). One patient required repeat ablation at 14 months, and the prolonged biliary excretions of 1 other patient ceased only at 8 months.

Conclusions: Cystic duct embolization with gallbladder ablation is a feasible procedure for patients in whom cholecystectomy is contraindicated.

MeSH terms

  • Ablation Techniques* / adverse effects
  • Aged
  • Aged, 80 and over
  • Cholecystectomy / adverse effects
  • Cholecystitis, Acute / diagnostic imaging
  • Cholecystitis, Acute / therapy*
  • Contraindications, Procedure
  • Cystic Duct* / diagnostic imaging
  • Embolization, Therapeutic* / adverse effects
  • Feasibility Studies
  • Female
  • Gallstones / diagnostic imaging
  • Gallstones / therapy*
  • Humans
  • Male
  • Polidocanol / administration & dosage*
  • Polidocanol / adverse effects
  • Prospective Studies
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Substances

  • Polidocanol